Enter your login e-mail to the account
Search
Search parameters
Search results
- Sekundární dyslipoproteinémie
MUDr. Michal Vrablík, PhD., doc. MUDr. Richard Češka, CSc.
(1/2004, Main topic ) - HyperCKemia – aetiology, clinical significance and differential diagnosis
Doc. MUDr. Peter Špalek, PhD.
(5/2018, Interdisciplinary consilium ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - Komentár k odporúčaniam ACC/AHA (ACC/AHA Guidelines on the Treatment of Blood Cholesterol)
MUDr. Ľubomíra Fábryová, PhD., prof. MUDr. Andrej Dukát, CSc., FESC
(2/2014, Information & comments ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - CLIMACTERIC AND THE CARDIOVASCULAR SYSTEM
MUDr. Ján Števlík
(6/2006, Main topic ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Pharmacological therapy and non-pharmacological measures in patient after myocardial infarction
prof. MUDr. Peter Mitro, PhD.
(2/2011, Review articles ) - Muscle cramps – causes, diagnostics and treatment
doc. MUDr. Peter Špalek, PhD.
(1/2023, Interdisciplinary consilium ) - Promoting prevention and treatment of cardiovascular disease through nutrition supplements
doc. MUDr. Štefan Farský, CSc., FESC
(5/2012, Review articles ) - Patofyziológia a farmakoterapia hypertenzného srdca
prof. MUDr. Fedor Šimko, CSc., FESC
(S1/2011, Supplement ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - MANAGEMENT OF PATIENTS AFTER CORONARY REVASCULARISATION PROCEDURES: GENERAL PRACTITIONER`S
prof. MUDr. Vasiľ Hricák, PhD., MFSC.
(4/2005, Topic ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - Dyslipidemia and diabetic foot syndrome
doc. MUDr. David Karásek, Ph.D., MUDr. Daniela Číhalíková
(2/2020, Review articles ) - Muscle cramps in general practice
doc. MUDr. Peter Špalek, PhD.
(6/2010, Interdisciplinary consilium ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - Hypolipidemic treatment and target values of lipids
MUDr. Ondřej Kyselák, prof. MUDr. Vladimír Soška, CSc.
(1/2019, Review articles ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Ezetimibe in the treatment of hypercholesterolaemia
doc. MUDr. David Karásek, Ph.D.
(3/2020, Review articles ) - THERAPY OF OBESE PATIENTS WITH DIABETES MELLITUS
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Habdáková
(12/2005, Topic ) - Statins and acute coronary syndrome
prof. MUDr. Ján Murín, CSc.
(1/2010, Review articles ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - PATHOPHYSIOLOGY OF HEART FAILURE
prof. MUDr. Fedor Šimko, CSc.
(9/2006, Main topic ) - New options in diagnostics and treatment of familial hypercholesterolemia
MUDr. Šárka Tesařová, Prof. MUDr. Michal Vrablík, Ph.D.
(3/2019, Review articles ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Svetový deň srdca 2009 aj s účasťou všeobecných lekárov
redakcia Solen
(10/2009, Focus ) - CHRONIC ISCHEMIC HEART DISEASE – STABLE ANGINA: CURRENT DIAGNOSTIC AND TREATMENT POSSIBILITIES
MUDr. Stanislav Juhás, CSc.
(11/2007, Topic ) - ACUTE MYOCARDIAL INFARCTION: ACTUAL MANAGMENT PRINCIPLES
I. interná klinika MFN, Martin
(11/2007, Topic ) - TREATMENT OF ARRYTHMIA AND PHARMACOTHERAPY POSSIBILITIES
doc. MUDr. Peter Mitro, PhD.
(11/2007, Topic )
- Mild cognitive impairment – Do we know more now?
MUDr. František Honzák
(1/2016, Digital publications ) - The antidepressants treatment in patients with high cardiovascular risk: benefit or risk?
MUDr. Radkin Honzák, Milan Vrána
(6/2009, Review articles ) - CURRENT TRENDS IN THE BIOLOGICAL TREATMENT OF ALZHEIMER DISEASE
MUDr. Roman Jirák, CSc.
(1/2006, Review articles )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Lipoprotein(a) as risk factor for ischemic stroke
MUDr. Antónia Lacková, MUDr. Miriam Kozárová, PhD.
(5/2021, Review articles ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Toxic myopathies
doc. MUDr. Edvard Ehler, CSc. , Prof. MUDr. Josef Zámečník, Ph.D.
(6/2016, Review articles ) - Statins and their influence on peripheral nervous system
doc. MUDr. Edvard Ehler, CSc.
(3/2020, Review articles ) - Drug-induced depression
doc. MUDr. Dana Končelíková, Ph.D.
(4/2021, From the boundary of neurology ) - Immune-mediated necrotizing myopathy
MUDr. Tomáš Kalous, prof. MUDr. Josef Zámečník, Ph.D.
(4/2017, Review articles ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Statins and neuroprotective effects
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN, PharmDr. Aleš Dvořák, MBA
(1/2021, Review articles ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Metabolism and sex, sex and metabolism
MUDr. Michaela Šnejdrlová, Ph.D.
(1/2017, SEXUAL AND REPRODUCTIVE MEDICINE FOR PRACTICE )
- Subacute cutaneous lupus erythematodes in a patient with SHARP syndrome – case report
MUDr. Barbora Gulánová, MUDr. Martina Part, PhD., prof. MUDr. Mária Šimaljaková, PhD, MHA
(2/2017, Original articles & case reports )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Active substances in medicinal mushrooms
MUDr. Jana Mrázová
(3/2016, Phytotherapy ) - Drug-induced depression
doc. MUDr. Dana Končelíková, Ph.D.
(2/2022, Current pharmacotherapy ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - Pharmacological treatment of peripheral arterial disease of lower limbs from a vascular surgeon’s point of view
prof. MUDr. Vladimír Šefránek, PhD.
(3-4/2012, Review articles ) - Abstrakty
(1/2009, Abstracts ) - High cardiovascular risk in patient with critical limb ischaemia – principles of conservative treatment
MUDr. Peter Gergely
(3/2011, Main topic ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes ) - Abdominal aortic aneurysm – percutaneous endovascular solution
MUDr. Juraj Maďarič, PhD., MPH, MUDr. Marek Tóth, MUDr. Terézia Urlandová, MUDr. Daniela Hladíková, MUDr. Jana Margitfalviová , MUDr. Tibor Balázs, MUDr. Erika Drangová, MUDr. Juraj Mikuláš, MUDr. Rastislav Bažík, MUDr. Andrej Klepanec, PhD., MUDr., Ivan Vulev, PhD., MPH
(S2/2013, Aortic díseases )
- Perioperative complications in thoracic surgery patients with metabolic syndrome
doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Michal Makovník, MUDr. Peter Poliak, PhD., MUDr. Juraj Koutun, CSc., MUDr. Stella Hlinšťáková
(4/2012, Original articles )
- The impact of the implementation of the resuscitation bundle on mortality in septic patients
doc. MUDr. Jozef Firment, PhD., MUDr. Tomáš Grendel, MUDr. Jana Šimonová
(1/2013, Original articles ) - Incidence and risk factors of delirium in patients after cardiac surgery
MUDr. Peter Čandík, PhD., MUDr. František Sabol, PhD., doc. MUDr. Pavol Török, CSc., MUDr. Dušan Rybár, MUDr. Stanislav Saladiak, MUDr. Boris Bilý, MUDr. Panayiotis Artemiou, PhD.
(1/2014, Original articles )